comparemela.com

Latest Breaking News On - Multiplexed - Page 1 : comparemela.com

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-200-A0201 Targeting HPV16 to Treat Solid Tumors

TSC-200-A0201 is TScan’s third cleared IND for the T-Plex solid tumor program supporting the use of multiple TCRs in combination to deliver customized, multiplexed TCR-T cell therapies based on. | June 6, 2023

Debora bartonHeather savelleGavin macbeathJoyce allaireCompany immunobankDrug administrationGlobe newswire tscan therapeutics incSecurities exchangeLifesci advisorsTscan therapeutics incChief medicalChief executive officerPrivate securities litigation reform actSecurities exchange actFinancial conditionAnnual report

PathogenDx, Inc : PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors

Company's Novel "Dynamic Dimensional Detection" Array Technology Delivers Unprecedented Performance in Multiplexing, Turn-Around Time, Throughput and Cost Per Test Scottsdale, Arizona (Newsfile Corp.

United statesEllen mellodyJonathan gossMichela protoPathogendx or companyArizona newsfile corpTechnology delivers unprecedented performanceTurn around timeCost perDimensional detectionPathogendx co founder

TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors

Primary IND for solid tumor program, T-Plex, supports simultaneous use of multiple TCRs to create customized, multiplexed TCR-T cell therapies based on target and HLA expression INDs for. | January 23, 2023

Davidp southwellTscan immunobankGavin macbeathHeather savelleJoyce allaireTscan therapeutics incLifesci advisorsSecurities exchangeDrug administrationCompany immunobankChief scientificChief executive officerPrivate securities litigation reform actSecurities exchange actFinancial conditionAnnual report

InDevR, Inc : InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

BOULDER, Colo., May 10, 2022for rapid and accurate assessment of pneumococcal vaccines at all stages of manufacturing, including multivalent drug product. This launch is accompanied by the availability

South mimmsUnited kingdomDavid boyleTerry salyerKostenloser wertpapierhandelErica dawsonMelinda gates foundationImage for indevr incRegulatory agencyLaboratory directorVaxarray pneumococcal assayVaxarray platformPneumococcal assayVaxarray pneumococcal kitVaxarray pneumococcal

RevoluGen Ltd : Quadram Scientists Demonstrate Advantages of Fire Monkey HMW-DNA Extraction with Multiplexed Oxford Nanopore DNA Sequencing for Complete Hybrid Assemblies of Pathogen Genomes

Data presented at Microbiology Society Annual Conference, Belfast, 4-7 April 2022 LONDON, April 5, 2022 /PRNewswire/ UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), welcomes

United kingdomCity ofOxford nanoporeGemma langridgeSue charlesWinniewy leeMariea chattawayGemmac langridgeJohn wainTyphis typhiJana haaseAmina ismail ahmedGeorgios patsosQuadram instituteUniversity of east angliaHead corporate communications

vimarsana © 2020. All Rights Reserved.